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In the experiments  now to be described,  the repeated administration of 3- 
methylcholanthrene exerted far reaching  effects on the endocrine system and 
metabolism  of the rat. Amongst the novel findings, it was learned that the 
compound  causes a  profound but selective depression of certain functions of 
the pituitary which is reflected in diminished  growth of hormone-dependent 
structures. Moreover,  significant metabolic  effects induced  by the compound 
were found to be reversible by appropriate modifications of the steroid status 
of the recipient.  Further, evidence  was obtained that 3-methylcholanthrene 
depresses  directly the growth rate  of transplanted mammary neoplasms  in 
the rat. 
It is known that certain cancers of the breast of human beings are dependent 
on hormones since these neoplasms undergo atrophy following suitable modifi- 
cations of the endocrine status of the host; the regression of metastatic cancer 
so induced can be both profound and of prolonged duration. There are several 
methods of hormonal control which are effective and all of them were discovered 
directly in clinical practise  without the benefit of pilot experimental  studies. 
Of the tumors of the breast presently available in the laboratory and thus far 
tested  only those mammary neoplasms  of the rat  known as fibroadenomas 
respond  in their growth rate to hormonal changes in the host and these tumors 
do not metastasize. 
Certain tumors of this sort possess in  high degree  the functional trait of 
responsiveness to hormonal modification of the host. Tumors of this class grow 
vigorously in adult female rats and their growth rate is profoundly depressed 
in animals subjected respectively  to  ovariectomy (1), adrenalectomy (2), or 
hypophysectomy (2),  to  the administration of testosterone (3)  or  of many 
related compounds  in the androstane series (4), or to the injection  of large 
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amounts of phenolic estrogens (2). These same procedures which do no more 
than result in profound retardation of the growth rate of the rat neoplasms have 
induced regression of mammary cancer in the human being. 
The  methods  mentioned  have  induced  no  regression  in  patients  suffering 
from mammary cancer which  is  not  dependent  on  hormones nor have  they 
proved  effective in  control  of  growth  of  a  class  of  transplanted  mammary 
fibroadenomas of the rat characterized by a low degree of hormonal dependence. 
The  removal of  the  hypophysis or  the  ovaries resulted  in  only  a  moderate 
retardation of the growth of such tumors in the rat (4). Moreover, the injec- 
tion of testosterone into the host has exerted only a  mild inhibitory effect on 
tumor growth.  In  the present  experiments,  however,  we have observed that 
3-methylcholanthrene or androstane derivatives depress somewhat the growth 
rate of mammary tumors of this  refractory  class  in  the  rat  while  the  com- 
bined  administration  of  3-methylcholanthrene  and  androstan-17fl-ol-3-one 
(dihydrotestosterone) profoundly retarded their growth. 
Prolonged administration  of 3-methylcholanthrene to various species  by various 
routes has produced mammary cancer in high incidence.  The repeated instillation of 
this compound, in the mouth (5) or the nares (6) of mice was followed by the develop- 
ment of mammary  cancer. Bielschowsky (7) observed that the feeding of another carci- 
nogen, 2-acetylaminofluorene,  for prolonged periods to adult female rats led to the 
development of mammary cancer in a high percentage of the animals. Shay a  a/. (8) 
administered 3-methylcholanthrene to adult female rats by intragastric instillation 
for many weeks and all of these animals developed mammary cancer. 3-Methylcholan- 
threne was excreted in the milk of lactating rats (9) following its administration by 
mouth, or by intravenous or intraperitoneal injection.  The intravenous injection of 
9,10-dimethyl-1,2-benzanthracene gave rise to mammary cancer in the rat (10). 
But it is known that certain polycyclic hydrocarbons can retard the growth of experi- 
mental neoplasms. Haddow (11) discovered that certain powerful carcinogens and also 
other  aromatic  hydrocarbons  with  little  carcinogenicity,  possess  the  property  of 
restraining the growth of transplanted tumors including  the Walker carcinoma and 
the Jensen sarcoma of rats and the Rous sarcoma of fowls (12). Among these tumor- 
inhibitory  compounds (11) were  5,6-cydopenteno-1, 2-benzanthracene, 1,2-benzan- 
thracene, 1,2,5 ~  6-dibenzanthracene, and 1,2-benzopyrene. 
In the experiments of Haddow the compounds were administered in one or more 
large doses by intraperitoneal injection; this method was found to be not free from 
objection since it produces peritonitis in mice (13). 
Haddow and Robinson  (12) expressed  the opinion that the retardation of tumor 
growth by polycyclic hydrocarbons was "clearly independent of toxic action in  the 
non-specific  sense." The tumor-inhibitory compounds  cause  a  decreased intake  of 
food and a  retardation of body growth although the general health and activity of 
the animals appeared to be good. Elsou and I-Iaddow (14) observed that the inhibitory 
action of 1,2,5,6-dibenzanthracene  upon the growth of the Walker carcinoma was 
dependent on the protein content of the diet since the tumor-inhibitory action of this 
hydrocarbon largely disappeared when the hosts were maintained on a  ration which 
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The administration  of carcinogens for long periods of time is known  to cause dis- 
turbances  of function in  the genital tract.  In  the experiments  of Brock,  Dmckrey, 
and  I-Iamperl (15)  the administration  of 3:4-benzopyrene  to rats  produced  atrophy 
of the genital apparatus which was more outspoken than the pathologic changes which 
were found in the other organs and  atrophy of the testis was specially outstanding. 
1,2,5,6-Dibenzanthracene  has been found  to cause prolonged gestation with  death 
and resorption of the fetuses (12,  16). 
In the experiments of Haddow and Robinson  (12)  there was some evidence for an 
interference with pituitary  function  in  rats  treated  with  1,2,5, 6-dibenzanthracene 
since these animals had  decreased fertility with suppression  of ovulation in some of 
the females and a  "variable reduction of spermatogenesis" in the males. 
Methods 
The experiments were carried out on transplanted fibroadenomas of two classes which were 
distinguished by quantitative differences of growth rate in response to hormonal modifications 
of the recipients. The tumors of both classes were derived from a single mammary fibroadenoma 
of spontaneous origin (2) and they have been m~ntalned in the laboratory by serial transplan- 
tations for 2 years. 
In most of the experiments mammary tumors characterized by high hormonal dependence 
(class  1) were used. These tumors grew at a considerable rate in adult female rats and very 
slowly in ovariectomized or hypophysectomized recipients and in adult male rats. 
In other experiments, always designated, a second sort of tumor (class 2) possessing  lower 
hormonal dependence was utilized. This tumor had arisen during long sojourn in a hypophy- 
sectomized host before retransplantation to adult females. Tumors of class 2 grew more rapidly 
in normal adult females than tumors of class 1 and the removal of the ovaries or the hypophysis 
was not very effective in retarding the growth of the transplants, which grew to a considerable 
size in hormone-poor environments. Tumors of class 2 also grew appreciably in intact adult 
males. 
All of the donors of the growths tested were untreated adult female rats bearing multiple 
tumors and when one of these tumors was excised some fragments were reimplanted in the 
donor. Consequently, repeated crops of its tumor were growing in the donor at all times per- 
mitting the use of tumors from few donors for many experiments. All of the studies were con- 
ducted  on tumors in their sixth or seventh passage from the first transplantation  from the 
original host. 
The recipients were albino rats of the Sprague-Dawley strain obtained from the dealer at 
age 42 days and kept thereafter under controlled climatic conditions. Most of the rats were 
fed a commercial ration. In certain experiments a high protein diet  (17),  was fed twice daily 
by gastric instillation to rats which, in addition, had free access to the commercial ration; the 
amount of the ration ingested was weighed each day. 
Each series of recipients consisted of 12 groups, each of 9 to 11 rats. The present observa- 
tions were based on 34 such series; in all, approximately 3600 rats were studied. In order to 
establish  control parameters  of growth  two groups were either untreated  or injected with 
sesame oil; these consisted of normal and  castrate females. Ovariectomy was performed at 
age 42 days. All the rats in the experimental series were intact adult females. All operations 
including transplantation  of tumors were performed under ether anesthesia. 
The tumor was transplanted into the groups of recipients when they were 51 days old. Fe- 
male rats of this age are adolescent and capable of much body growth but the estrus cycles 
have been established in nearly all of them. The tumor was excised, sliced, and oval fragments 
were cut from the slices with a surgical  punch. The implants measured about 8 x 5 x 5 ram. 16  EFFECTS OF 3-METHYLCHOLANTHRENE 
and weighed about 50 to 70 mg. Every tenth fragment was weighed and the standard deviation 
of these weights  was calculated. Eight pieces of tumor were implanted subcutaneously in 
widely separated places through small incisions in the mid-back and in the epigastrium. 
3-Methylcholanthrene was dissolved in sesame oil and when crystals formed in the oil at 
room temperature the compounds  were heated briefly at 100°C. Steroids were dissolved in 
ethyl alcohol which was diluted with sesame oil to make the final alcoholic concentration 10 
per cent. When 3-methylcholanthrene  was injected with steroids the compounds were dissolved 
in the same solution. The solution (0.2 ml.) was injected, intramuscularly, alternately in each 
hind leg 6 days each week for 6 or 7 weeks. Throughout this paper, dosage refers to the amount 
administered each day. 
In certain experiments,  equine gonadotrophin~ was injected daily dissolved in saline  (0.5 
hal.); the dosage of this substance is expressed in the units of Cartland and Nelson  (18). 
Each experiment was repeated on 3 or more separate occasions. 
At necropsy,  always 40  to 50 days after transplantation, the tumors, pituitary, adrenal 
glands, preputial glands,  prostates, ovaries,  and uteri were weighed on a precision balance. 
The statistical probability, p, of a significant effect was derived from Fisher's (19) table of t 
values. Histologic preparations of tumors from each group were always studied. The site of 
alkal~e phosphatase was determined in slices of the tumor, the mammary glands, and the 
vagina by the method of Gomori (20). 
The content of alkaline phosphatase was measured  in an inguinal mammary gland by a 
method described  earlier (4);  the results are expressed in the units of King and Armstrong 
(21). 
EXPERIMENTAL 
The repeated administration of 3-methylcholanthrene to rats resulted in few patho- 
logic changes which were recognized at the end of 50 days. A  small number of the 
treated  rats contracted  respiratory or gastro-intestinal infections despite efforts to 
maintain the colony free from disease and groups of rats with intercurrent infections 
were always discarded. In rats injected with estradiol-17fl, 1 /~g., progesterone 4 rag., 
and  3-methylcholanthrene,  2  mg.,  in  the  same  solution, squamous  metaplasia was 
found in many of the mammary ducts. Neoplasms attributable to the administration 
of 3-methylcholanthrene were not observed. 
Intragastric  and  Intramuscular  Administration  of 3-Methylcholanthrene.-- 
On comparison with values in untreated rats (Table I) the daily introduction 
of 3-methylcholanthrene,  2  rag.  into  the  stomach  resulted  in  (a)  a  slight re- 
tardation of gain in body weight of the adolescent rats; (b) a  moderate reduc- 
tion  in  the  size of  the  transplanted mammary  fibroadenomas;  and  (c)  a  de- 
creased  content  of  alkaline  phosphatase  in  the  inguinal  mammary  glands. 
Increasing the  dosage of 3-methylcholanthrene to  5  rag. intensified all of the 
effects. 
Similar findings were  observed in  rats  treated  with  3-methylcholanthrene, 
1  rag.,  administered  by  intramuscular  injection;  likewise,  the  effects  were 
augmented  when  the  dosage  was  increased  to  2  rag.  With  respect  to  the 
a We acknowledge with gratitude generous gifts of equine gonadotrophin  (gonadogen) from 
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effects on growth, the intramuscular injection of 3-methylcholanthrene,  1 mg., 
was equivalent to a  dosage of 2 rag. by gastric instillation. 
Despite the decrease of alkaline phosphatase in the breast, atrophy of the 
mammary glands  was  never  observed  in  rats  treated  with  3-methylcholan- 
threne.  Actually,  hyperplasia  of  the  mammary epithelium  (Figs.  1,  2)  was 
present in 8 rats in a group of 50 treated animals whose mammary glands were 
subjected to histological examination. 
TABLE I 
Inkibltory Effect of 3-Metkylcholanthrene on the Growth of a Mammary Fibroadenoma 
3-Methylcholanthrene was administered for 50 days and  10 intact female rats were in- 
duded as controls in each group. A is the gain in body weight during the experimental period. 
"Alkaline phosphatase" indicates the content of this enzyme in the inguinal mammary  gland. 
Compound and daily  dose 
Intact rats; no instillations 
3-Methylcholanthrene, 2 rag. 
3-Methylcholanthrene, 5 rag. 
Tumor 
A 
Mean  Percentage 
weight  of controls 
gm.  m&. 
(~) Intragastrie  instillation 
2,14 
53  160 
(b) Intramuscular  injection 
1773 
759 
484 
119 
104 
88 
82 
72 
145 
92 
Intact rats; no injections 
3-Methylcholanthrene, 1 rag. 
3-Methylchoianthrene, 2 mg. 
Ovariectomized; no injections 
Ovariectomized and 3-Methylcholan- 
threne, 2 rag. 
36 
100 
7 
6 
Alkaline 
phosphatase 
un~s* 
1.30  .a,_ 0.30 
0.88  ~  0.20 
0.76  .4-  0.18 
1.61  4-  0.4 
0.83  4-  0.1 
0.82  ~  0.1 
0.84  -4-  0.1 
0.76  -4-  0.8 
* King-Armstrong units with standard deviation. 
Effect on Tumor Growth of the Concurrent Administration of 3-Metkylckolantkrene 
witk Progesterone  and Estradiol-170.-- 
It is known  (2)  that  large  doses of progesterone and  critical  amounts  of 
estradiol-17~,  administered  separately  or  together,  enhance  the  growth  of 
transplanted  mammary fibroadenomas of class  1.  In addition,  these  steroids 
promote vigorous growth of the mammary gland, and with an accompanying 
increase of alkaline phosphatase in this tissue. 
When 3-methycholanthrene,  1 rag. was administered together with proges- 
terone 4 nag.,  (Table II) the growth of the transplanted  tumor was much re- 
duced.  Histological examination indicated  that  the gestational growth of the 
mammary glands  ensuing  from the  administration  of progesterone  was not 
diminished  by  the  supplementary  administration  of  3-methylcholanthrene; 
also, there was no decrease of the content of alkaline phosphatase in the breast. 18  EFFECTS  OF  3-METHYLCHOLANTHRENE 
Estradiol-17fl,  0.1  /zg. or  1  gg.  augmented  the  growth  of  the  tumor  and 
promoted the growth of the mammary glands. The concurrent administration 
of  3-methylcholanthrene,  1  rag.  or  2  rag.,  with  estradiol-17fl  in  the  stated 
amounts abolished the tumor-stimulating effect of the phenolic estrogen whilst 
the growth of the mammary epithelium and the accompanying rise of alkaline 
phosphatase  remained  unaffected  (Table  III)  by  the  injection  of  the  poly- 
cyclic hydrocarbon. 
TABLE II 
Partial Inhibition of t~rogeslerone-Stimulaled Growth of Mammary Fibroadenoma by 
3-Methylckolanthrene 
The compounds were administered for 40 days, with 10 intact female rats in each group 
as controls. A is the gain in body weight during the experimental period. Alkaline phospha- 
tase indicates its content in an inguinal mammary  land. 
Compound and daily dose 
Progesterone, 4 mg 
Intact rats; no injections 
Progesterone,  4  rag.,  and  3-methyl- 
cholanthrene, 1 rag. 
3-Methylcholanthrene, 1 rag. 
grit. 
129 
73 
96 
60 
Tumor 
Percentage 
Mean weight  of unin- 
iected con- 
trois 
mg. 
9981  676 
1476  100 
1365  92 
906  61 
Alkaline 
phosphatase 
units* 
2.83  -4-  1.17 
1.40  -4- 0.14 
2.76 4- 1.05 
0.70  4- 0.07 
* King-Armstrong units with standard deviation. 
Estradiol-17fl,  1  #g.  administered  with  progesterone,  4  nag.,  induced  pro- 
found growth  both  of the  transplanted  tumor and of the normal mammary 
glands of the host; when 3-methylcholanthrene,  2 rag., was administered as a 
supplement  to  these  steroids,  the  growth  of  the  tumor  was  much  reduced 
(Table III) whilst the growth of the mammary tree was undiminished. 
Influence of 3-Methylcholantkrenc and Dikydrotestosterone on Growth of Mammary 
Fibroadenomas with  Varying  Hormone Dependence.- 
Tumors of class 1 grew well in intact adult females whereas the growth in 
ovariectomlz~ed rats was sluggish; these tumors are highly dependent on steroid 
hormones of ovarian  origin.  The  intramuscular  administration  of 3-methyl- 
cholanthrene,  2 rag., restrained moderately the growth of these tumors, whilst 
dihydrotestosterone profoundly inhibited their growth (Table IV a). 
Tumors of  class  2  grew  rapidly  in  adult  females (Table  IV b)  and  their 
growth in ovariectomized rats, while somewhat less than in the intact sisters, 
was still vigorous; these tumors have low hormone dependence. The adminis- 
tration  of 3-methylcholanthrene,  2  rag.,  or  of dihydrotestosterone,  1  mg  to CHARLES  HUGGINS  AND  LUCIO  POLLICE  19 
TABLE IH 
Inhibitory Effects of 3-Methylcholanthrene on Growth of Fibroadenomas in Rats  Injected 
Concurrently with Estradiol-17B 
The compounds were injected intramuscularly  for 40 days and there were 10 intact female 
rats in each group. 
Compounds  and daily dose  Mean tumor  Alkaline 
weight  phosphatase 
Estradiol-17~, 1 ag. 
Estradiol-17~, 0.1 t~g. 
Intact rats; no injections 
3-Methylcholanthrene, I rag. 
Estradio1-17~, 0.1 ~g. and 3-methylcolanthrene 1 rag. 
Estradiol-17~, 1 ~g. and 3-methylcholanthrene 1 rag. 
Estradiol-17~, 0.1 ~g. and 3-methylcholanthrene, 2 nag. 
3-Methylcho]anthrene, 2 nag. 
Estradiol-17fl,  1/~g., progesterone, 4 rag. 
Estradiol-17~, 1 ~g., progesterone, 4 rag.,  3-Methylcholan- 
threne, 2 rag. 
rag. 
1935 
1935 
1097 
424 
405 
399 
349 
135 
8130 
1632 
units* 
2.26  -4-  1.0 
2.38  -4- 0.8 
1.40±0.1 
0.66  :t:  0.1 
2.65  ~-  1.0 
2.46  -4- 0.8 
0.66  ±  0.1 
4.07  4- 0.I 
4.03  ±0.1 
* King-Armstrong  units with standard deviation. 
TABLE IV 
Influence of 3-Metkylchotontkrene and Dihydrotestosterone on Growth of Two Mammary Fibro- 
adenomas Exhibiting Various Degrees of Hormonal Dependence 
There were 10 rats in each group and the duration of the experiment was 40 days. 
Compound  and daily dose 
(a) Tumor with high hormonal dependence (class I) 
Intact rats; no injections 
Ovariectomized; no injections 
Intact rats; 3-methylcholanthrene, 2 rag. 
Intact rats; dihydrotestosterone, 1 nag. 
Intact rats; 3-methylcholanthrene, 2  rag.  and dihydrotestosterone, 
I nag. 
(b) Tumor with low hormonal dependence (class 2) 
Intact rats; no injections 
Ovariectomized; no injections 
Intact rats; 3-methy]cholanthrene, 2 rag. 
Intact rats; dihydrotestosterone, 1 rag. 
Intact rats; 3-methylcholanthrene, 2 rag.  and dihydrotestosterone, 
I rag. 
Mean tumor weight 
mg. 
612 
127 
202 
35 
28 
4896 
3524 
1536 
1295 
189 
intact female rats depressed somewhat, and approximately to the same extent, 
the growth of these tumors (Table IV b). The growth of tumors of class 2  was 
restrained  profoundly  in  rats  treated  simultaneously  with  3-methylcholan- 
threne,  2  rag.,  and  dihydrotestosterone,  1  mg.  (Table  IV  b).  In  animals  so 20  E:F~'ECTS  OF  3-METHYI,CHOLANTEILENE 
treated the number of "takes" (5 per cent) was much smaller than in uninjected 
controls  (88 per cent).  The transplants which survived were very small (Fig. 
3)  after 50 days of treatment. 
The  tumors  whose  growth  had  been  depressed  by  the  administration  of 
3-methylcholanthrene  did  not  differ in  histological  appearance  from rapidly 
growing tumors of untreated mates bearing the same transplanted neoplasm; 
the  compound  had  retarded  the  growth  of  the  tumor  without  inducing  obvious 
cytologic changes. 
TABLE  V 
Effects of 3-Methflckolantkrene in For~e-Fed Rats 
3-Methylchoianthrene, 2 rag., was injected for 50 days with 10 intact female  rats in each 
group; the control rats were injected with sesame oil. A is the increase in body weight during 
the experiment. The rats were fed by gastric intubation and in addition had free access to a 
commercial ration. 
a Body weight, gra  ......................... 
Mammary fibroadenoma, rag  ................ 
Ovaries, rag  ............................... 
Uteru% rag  ................................ 
Preputial glands, mg  ....................... 
Pituitary,  mg  ............................. 
InJected with  Controls  3-methylcholanthrene 
114 
686 
894-8 
436 
134 4- 30 
13.4  4-  1.6 
Alkaline phosphatase, King-Armstrong  units 
Mammary glands* ..........................  ]  1.22  4-  O. 1 
SerumS; ...................................  1  59.9  4-  4.0 
111 
27O 
61 
323 
81 
11.0 
0.85 
63.8 
4-8 
4-  16 
4-1 
4-0.1 
4-5.2 
Mean values are given. 
4-, standard deviation. 
* Content in an inguinal mammary gland. 
Units in 100 ml. 
Metabolic  Eff~ts  of 3-Methylckolantkrer~.-- 
The intramuscular  injection of 3-methylcholanthrene,  2  nag.,  into  the ado- 
lescent females resulted in a  moderate retardation of body growth which was 
manifest in  a  diminished  rate of increment of body weight.  This decrease of 
body growth was apparent within 5 days after commencing the administration 
of the compound. The diminished gain of weight was overcome in rats which 
were force-fed with the protein-rich diet employed in  the experiments. In the 
force-fed rats  injected  with  3-methylcholanthrene,  the  retardation  of growth 
of the transplanted tumor was still evident (Table V). 
The retarded rate of gain of body weight induced by 3-methylcholanthrene 
was overcome, in rats maintained on an at/libitum ration, by other methods, 
namely, by modifications of the endocrine state. The concurrent injection of 3- 
methylcholanthrene  with dihydrotestosterone,  1 rag., or progesterone, 4  rag., CHARLES HUGGL~S AND  LUCIO POLLICE  21 
resulted in a gain of body weight which exceeded that of the control rats (Text- 
fig.  1) either untreated or injected with sesame oil. The rate of increment of 
body weight of rats treated with either of these steroids plus 3-methylcholan- 
threne greatly exceeded that of their mates treated with 3-methylcholanthrene 
in the absence of the steroids but it was somewhat less than the growth of rats 
treated with the steroids only, 3-methylcholanthrene having been omitted. 
Females treated with 3-methylcholanthrene gained less weight than injected 
males did  (Table VI). Moreover, ovariectomy had  a  beneficial  effect on the 
GM-  BODY  WEIGHT 
300 
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TEXT-Fzo. 1. The influence, respectively, of dihydrotestosterone,  1 rag., and progesterone 
4 nag., on the growth of rats injected concurrently with 3-methylcholazlthrene, 2 rag. 
growth of treated females since ovariectomized females injected with 3-methyl- 
cholanthrene  gained more weight than  their  treated intact  sisters  (Table I). 
Whilst  ovariectomy protected  female  rats  from  the  catabolic  effects of  3- 
methylcholanthrene and the gain in body weight of the treated rats exceeded 
that of untreated sisters with normal ovarian function, the increment of body 
weight was less  than  that  which occurred in ovariectomized females not in- 
jected with 3-methylcholanthrene  (Table I). 
Effect  of 3-Methylcholanthrene on Endocrine  Glands and  Hormonal  Targets.- 
As compared with the values obtained in animals injected with sesame oil 
the injection of 3-methylcholanthrene,  1 nag., in female rats resulted  (Table 
VII) in a decrease of (a) total body growth; (b) ovarian weight; (c) weight of 22  EFFECTS  O$'  3-M:ETHYI,CHOLANTHI~ENE 
the uterus; (d) weight of the preputial glands; (e) the content of alkaline phos- 
phatase of the mammary glands; (f) the weight of the pituitary (the statistical 
probability of significance was p  <  0.01).  At a  dose level of 3-methylcholan- 
threne, 2 mg., all of these effects were intensified (Table VII). 
There was no decrease in  the weight of the  adrenals in  rats injected  with 
3-methylcholanthrene,  1 rag., but a  moderate diminution of their weight was 
observed at a  dose level of 2 mg. of this compound. At neither level of dosage 
TABLE  VI 
Differential Effects of 3-Methylcholanthrene on Endocrine Structures of Male and Female Rats 
3-Methylcholanthrene, dissolved in sesame oil, was injected intramuscularly for 50 days 
beginning at age 51 days; the controls received sesame oil only. The males received a larger 
dose of the compound, both absolute and in terms of 100 gin. of initial body weight, than the 
females got. Mean weights of the structures are given; A is the gain in body weight during 
the experiment. 
(a)  Females.  Dose of 3.-melhylol$olanll~ro~, 2 rag. (0.78 mg./lO0 gin.) 
Compound  A  Ovaries  (2)  Adrenals  (2)  Uterus  Pituitary 
gm.  mg.  mg.  mg.  rag. 
Sesame oil ..................  99  80  79  544  14.34-1.1 
3-Methylcholanthrene ........  53  36  61  178  8.94-0.8 
Percentage decrease  ...........  -46  -55  -23  --67  -38 
(b) Males. Dose of 3-Methylclwlanghreno,  2.5 rag. (1.25 rag./lO0 gin.) 
A  Testis (1)  Adrenals  (2)  Prostate (1)  Pituitary 
gm.  mg.  mg.  rag.  rag. 
Sesame oil ...................  195  1682  67  315  14.04-2.2 
3-Methylcholanthrene .........  124  1619  55  187  11.74-1.0 
Percentage decrease  ...........  -36  -4  -18  -41  --18 
4-, standard deviation. 
of 3-methylcholanthrene was there a  significant change in the content of alka- 
line phosphatase in  the serum (Table VIII). 
Histological examination of the vagina of intact rats treated with 3-methyl- 
cholanthrene revealed that  estrus was uncommon (8 per vent of the rats)  and 
atrophy of the vaginal epithelium  (4 per vent) was even more so. The vaginal 
mucosa of most of the rats was lined with low stratified epithelium. 
In the male, the administration of 3-methylcholanthrene,  2.5 rag., lessened 
the normal increment of body weight and resulted in a  decrease in the weight 
of the adrenals and pituitary with reference to  the  controls  (Table VI), but 
all  these  changes were of less magnitude than those occurring in the  females CHARLES HUGGINS AND LUCI0 POLLICE  23 
injected with lower doses of the compound. In the male, there was a  decline 
in the weight of the ventral prostate but no significant changes in the weight 
of the testis. In all the males receiving 3-methylcholanthrene,  2.5 rag., highly 
motile spermatozoa were present in the vas deferens at necropsy. The testes 
of 10 rats were studied  histologically. The germinal epithelium in  9  rats was 
similar to that of untreated animals but in one testis patches of tubules were 
devoid of germinal epithelium whilst other tubules appeared to be quite normal. 
TABLE VII 
Effe~Is  of 3-Methylckolantkrene  on  Endocrine  Structures  in the Female 
3-Methylcholanthrene dissolved in sesame oil was injected for 50 days while the controls 
received sesame oil only. There were 10 control female rats in each group. A is the increase 
in body weight during the experiment. Mean values are given. 
A body weight, gm  .................. 
Ovaries, rag  ........................ 
Uterus, mg  ........................ 
Preputial glands, mg  ................ 
Controls: injected 
with sesame oil 
88 
90 
484 
127 
Rats injected with methylcholanthrene 
82 
4-  17  61 
442 
83 
4-6  88  Adrenal glands, mg  .................  74 
Pituitary,  mg  ......................  14.5  4-  1.2  12.4 
Alkaline pkospkatase, King-Armstrong units 
Mammary glands* ..................  1.61 4- 0.4  [  0.83 
Serum~  ............................  59.9  4- 4.0  I  60.2 
Irag.  2mg. 
72 
-4-  12  50  4-  13 
233 
6O 
4-9  654-1 
4-  0.8  9.5  4-  0.8 
4-  0.1  0.82  4-  0.1 
4-  6.2  63.8  4-  5.2 
+, standard deviation. 
* Content in an inguinal mammary  gland. 
Units in 100 ml. 
Concurrent  Administration  of Gonadotropkin  and  3-Methylckolantkrene.-- 
The administration of equine gonadotrophin was found to overcome  the tumor- 
inhibitory effects of 3-methylcholanthrene and  to restore growth of the neo- 
plasm to a  size comparable to that found in intact rats untreated with either 
substance. But  the doses of the protein hormone were critical for this restora- 
tion; large quantities of gonadotrophin were relatively ineffective in promoting 
tumor growth. 
In rats treated with 3-methylcholanthrene,  2 rag., the growth of the trans- 
planted fibroadenoma was retarded.  When this compound was supplemented 
with equine gonadotrophin, 0.02 units, growth was not promoted in any tissue. 
Stimulation of the growth of the tumor (Text-fig. 2)  occurred when the dose 
of the protein hormone was 0.05  units.  At a  dose level of 0.1  units of equine 
gonadotrophin,  the  growth  of  the  tumor  was  maximal  and  it  exceeded  the 
growth  in intact untreated  control  rats.  When  the dosage of equine gonado- 24  EFFECTS  OF  3-M_ETHYLCHOLANTHRENE 
trophin  was 0.4 units,  growth of the tumor was submaximal and only slight 
growth of the tumor occurred at a  dose level of 1 unit (Table VIII). Equine 
gonadotrophin,  0.05  to 0.4 units,  induced a  gestational  type of proliferation 
with the secretion of small  amounts of mill~ in the transplanted  tumors. 
In contrast with its effects on the transplanted neoplasms, increasing  doses 
of equine gonadotrophin  induced progressive growth of the uterus and ever- 
increasing  gestational changes in the mammary glands in daily doses of 0.05 
to  1 unit  in rats  treated  concurrently with  3-methylcholanthrene.  Likewise, 
progessive growth  of  the  ovaries occurred  corresponding  with  an  increased 
TUMOR  ~  42 
WEIGHT 
MG  MC  2MG. 
i~oc -  ~  GONAD~TROPHIN  o 
sOo 
lOG 
I  I  I  I  IEqUINE GONADOTROTROPI'-IIN I 
0  0.02, 00,5  O.t  0.2  UNITS  /  DAY  0-4 
TExT-FIG.  2.  The effects of increasing quantities of equine gonadotrophin on the growth 
of a mammary fibroadenoma in intact rats injected concurrently with 3-methylcholanthrene, 
2 rag. The growth of the tumor in untreated control rats is indicated by the dashes (---). 
dose of the protein hormone but no significant  increment  of ovarian weight 
was observed until the dosage of equine gonadotrophin exceeded 0.1 unit. 
When equine  gonadotrophin  was injected concurrently with 3-methylchol- 
anthrene,  2  mg.,  muclfication of the vaginal  epithelium  of gestational  sort 
was observed when the dosage of equine gonadotrophin  was 0.1 to 0.4 units, 
but only in a minority of animals; vaginal mucification of this kind occurred 
in 2 rats in a series of 12 animals whilst the vaginal epithelium of the others 
was  characterized  by  profound  growth  of  stratified  epithelium  containing 
slight amounts of mucin. The vaginal epithelium of rats injected with equine 
gonadotrophin,  1 unit, was stratified and did not resemble the vaginal mucosa 
of pregnancy. 
Equine gonadotrophin, 0.1 unit, failed to augment the growth of the tumor 
in ovariectomized rats. CHARLES  HUGGINS  AND  LUCIO POLLICE  25 
TABLE VIII 
Effects  of  Concurrent Administration  of  3-Methylcholanthrene and  Gonadotropkin 
3-Methyleholanthrene,  2 mg., was injected  intramuscularly  for 50 days with 10 control 
female rats bearing  transplanted  fibroadenoma in each group.  Equine  gonadotrophin,  dis- 
solved in saline, was  injected  subcutaneously.  Mean weights are given. 
3-Methylcholanthrene, 2 rag., plus  Proliferation in 
Gonadotrophin  Tumor  Ovaries  Uterus  tary gland* 
Unltsf 
None 
0.02 
0.05 
0.1 
0.4 
1.0 
Controls: no gonadotrophin or 
3-methylcholanthrene 
mg. 
171 
327 
681 
820 
mg. 
47 
44 
56 
6O 
mg. 
274 
288 
425 
614 
724 
137 
1027 
306 
563 
80 
966 
1259 
437 
0 
0 
++ 
+++ 
++++ 
* Gestational proliferation rated from slight (+) to profound (++++). 
:~ Equine gonadotrophin expressed in Cartland-Neison  units. 
-4-, signifies that proliferation was not present in all animals. 
TABLE IX 
Intribitory Effect of 3-Methytckolantkrene on the Growth of a Mammary  Fibroadenoma in 
Hypopkysectomlced Rats 
There were 15 rats in each  group and 3-methylcholanthrene was administered for 53 days 
to 1 group of hypophyscctomized rats. A is the gain in body weight during  the experiment. 
Intact females; no injections 
Ovariectomized; no injections 
Hypophyscctomized; no injections 
Hypophysecsomized; injected  with 3-methyl- 
cholanthrene 0.5 rag. 
84 
107 
7 
1 
Mean Tumor weight 
mg, 
7427 
3053 
1777  • 
668 
Inhibitory Effect of 3-Methylckolanthrene  in Hypopkysectomized  Rats.-- 
The growth characteristics  of a  tumor in class 2  are given in Table  IX. 3- 
Methylcholanthrene, 0.5  rag.,  was  administered  to  hypophysectomized  rats 
bearing this tumor and the growth of the neoplasm was considerably retarded 
(Fig. 4) but it was not abolished.  It is noteworthy that the repeated injection 
of 3-methylcholanthrene,  0.5 rag., did not induce a  loss of body weight (Table 
IX). 
DISCUSSION 
The  oral  or  intramuscular  administration  of  3-methylcholanthrene  in  re- 
peated  doses  was  found  to  result  in  retardation  of  growth  of  transplanted 26  EFFECTS OF 3-~ETHYI~HOLANTHRENE 
mammary tumors and there was an associated decrease in the body growth of 
adolescent females.  In 1914, Rous (22) pointed out the important influence of 
diet upon the growth of some, but not of all, types of transplanted  tumors in 
demonstrating  that  certain  varieties  of neoplasms grow badly in rats much 
underweight.  In  more recent years, Tannenbaum  (23)  has  stressed the pro- 
found influence of even moderate caloric restriction on the genesis of spontane- 
ous and induced tumors.  In the experiments of Elson and Haddow (14)  the 
inhibiting action of 1,2,5,6-dibenzanthracene  upon the growth of the Walker 
carcinoma in the rat was found to be dependent on the protein content of the 
diet. In our experiments with force-fed animals which became overweight when 
maintained  on a  high  protein  diet,  3-methylcholanthrene  had  an  inhibitory 
effort on the growth of the transplanted mammary tumors. It follows that the 
inhibition  was not due  to emaciation  exclusively. 
Body growth was not stopped but it was retarded by the repeated adminis- 
tration  of 3-methylchoianthrene  to the young rats.  The slackening  of growth 
was observed within 5 days after beginning  the treatment. The treated animals 
gained weight in a regular and orderly way but more slowly than their untreated 
intact  sisters.  The treated rats were forced to gain weight at an accelerated 
rate by modification of the hormonal milieu intgrieur through  the administra- 
tion or withdrawal  of appropriate  steroids. 
The rate of body growth was considerably increased in rats injected with 3- 
methylcholanthrene  together with dihydrotestosterone or progesterone.  Ani- 
mals, so treated, gained weight more rapidly than their uninjected intact sisters 
but not so rapidly as rats injected with  these steroids in  the absence of the 
polycyclic hydrocarbon. 
The protective anabolic effect of testosterone on body growth was also seen 
in the observation that the depressive effect of 3-methylcholanthrene on body 
growth was less drastic in the males than in the female rats. Moreover, intact 
male rats injected with 3-methylcholanthrene gained more weight than  simi- 
larly treated castrate mates deprived of androgenic hormones by orchiectomy. 
The administration of phenolic estrogens (24) is known to depress the growth 
rate  of  the  normal  rat  whilst  ovariectomy accelerates  body growth.  These 
endocrine  modifications  are  similarly  operative  in  rats  subjected to  the  re- 
peated  administration  of  3-methylcholanthrene.  In  rats  injected  with  this 
polycyclic hydrocarbon,  the  supplementary  administration  of  estradiol-17~ 
profoundly retarded the body growth. The weight of ovariectomlzed rats in- 
jected with  3-methylcholanthrene  exceeded that  of untreated  intact  control 
females. 
These findings account for the opposite effects of gonadectomy on the metab- 
olism  of males and females injected with 3-methylcholanthrene.  Orchiectomy 
by removing testosterone which has anabolic properties d~mlrfishes growth of 
rats  injected  with  3-methylcholanthrene;  ovariectomy  removes  phenolic CHARLES  HUGGINS  AND LUCI0 POLLICE  27 
estrogens,  which promote catabolism, and so the removal of the ovaries en- 
hances body growth of the treated animals. 
The biochemical  mechanisms by which progesterone and  testosterone pro- 
mote body growth whilst phenolic  estrogens and 3-methylcholanthrene retard 
growth are  -n]~nown.  All of the  steroids and  3-methylcholanthrene  as well 
are lipophilic  compounds which possess the phenanthrene structure. We postu- 
late that the influence of all of these compounds on growth, divergent in direc- 
tion as their effects on metabolism are, operate through the same cell mechanism. 
The state of the hormonal  target organs in our experiments indicated that 
the  administration  of 3-methylcholaathrene  depressed,  but  did  not  abolish, 
pituitary function. In the treated rats, the vaginal epithelium was hypoplastic 
but seldom completely atrophied;  the  uterus while underweight  was not  so 
small  as that of hypophysectomized rats. It is known that caloric  restriction 
results in a depression of pituitary function, most notably involving gonado- 
trophinswthe  pseudo-hypophysectomy of Mulinos and Pomeranz,  (25).  Mal- 
nutrition was not the sole or critical  factor in the depression of endocrine func- 
tions in the present experiments for there was a decline  in size of the ovaries 
and  the pituitary  in  treated  rats  which  were overweight because of forced 
feeding. 
The lessening  of pituitary activity resulting from the administration  of 3- 
methylcholanthrene is selective since not aU hypophyseal functions are equally 
depressed by the compound. In the treated aaimals,  decrease in the weight 
of the ovaries was always more profound than the relative decrease of adrenal 
size which ensued. In fact, a dosage of 3-methylcholanthrene (I rag. daily) was 
found which resulted in a  decline  in ovarian weight without any decrease of 
,weight  of the adrenal  glands. 
Additional evidence for the selective depression of pituitary function resulting 
from the repeated administration  of 3-methylcholanthrene was gleaned from 
the differential  effects on the male and the female gonad, respectively. In both, 
there was a decreased production of gonadal hormones as demonstrated by a 
decline of prostatic weight or of uterine weight. In the male rat, although large 
doses of the  compound were administered,  there  was neither  a  decrease in 
weight of the testis, nor, in most instances,  a profound change in its histological 
appearance, and highly active spermatozoa in large numbers were present in 
the vas deferens at the end of the experiment. In the female rat,  there was a 
great decrease of ovarian  weight with histological  evidence of hypoplasia of 
the follicles. Yet, in the rats treated with 3-methylcholanthrene, growth of the 
ovary was profoundly stimulated by simultaneous injection of gonadotrophin. 
Clearly, the administration  of 3-methylcholanthrene had not directly affected 
the ovary since it grew in response to appropriate hormonal stimulation in the 
presence of this compound. 
The differential  effects on the testis brought about by the repeated adminis- 28  E~'~ECTS  O1~  3-METHYLCHOLANTHREN~ 
tration of 3-methylcholanthrene resemble the gonadal findings  in elderly men 
in  whom the production of testicular  hormones is usually diminished  whilst 
the production of spermatozoa  commonly continues throughout  life however 
prolonged it may be. 
The repeated administration of 3-methylcholanthrene resulted in remarkable 
changes in the mammary glands which were concerned with their content of 
alkaline phosphatase  when  considered  in relation  to proliferation.  Following 
ovariectomy  in  untreated  rats  a  significant  decline  of alkaline  phosphatase 
content of the breast ensued and it was associated with atrophy of the mammary 
tubules. There was a  decrease of alkaline  phosphatase of comparable magni- 
tude in the mammary glands of intact rats treated with 3-methylcholanthrene 
but atrophy of the mammary  epithelium  was not observed--in fact, hyper- 
plasia  was often found.  It  is known  that  the  repeated  administration  of 3- 
methylcholanthrene for 6 or more months (9) leads to mammary cancer in the 
rat.  The  phosphatase-poor  proliferation  of  the  mammary  epithelium  may 
represent  a  precancerous  stage.  The  decline  in  alkaline  phosphatase  in  the 
mammary glands of rats  treated with 3-methylcholanthrene  is a  local  effect 
on this tissue; there was no decrease in the content of this enzyme in the blood 
serum. 
The proliferation  of the mammary  epithelium  and  the accompanying rise 
of alkaline phosphatase induced in rats by the administration of steroids which 
promote growth  of the mammary  gland  (dihydrotestosterone; estradiol-17/~; 
progesterone) were not diminished  by the simultaneous injection of 3-methyl- 
cholanthrene. 
The repeated administration  of 3-methylcholanthrene slowed the growth of 
transplanted mammary tumors of class 1 but was less effective than dihydrotes- 
tosterone  in  this  regard.  The  administration  of equine  gonadotrophin  fully 
restored the growth of the tumor in rats injected with 3-methylcholanthrene 
and the size of the neoplasm came to approximate that of the growths in un- 
treated intact females.  Critical amounts of gonadotrophin were involved since 
exceeding  the maximal  effective dose resulted in tumors of submaximal size. 
Studies of the vaginal epithelium indicate that considerable quantities of estro- 
genic hormones were produced in the excessive stimulation with gonadotrophin 
and  large  amounts  of phenolic estrogens are known  to block the growth of 
transplanted  mammary  fibroadenomas  (2). 
Although  the  depression  of gonadotrophin  by 3-methylcholanthrene is of 
high importance in the retardation of growth of the transplanted  tumors, the 
depressed production of this pituitary factor was not the sole mechanism  in- 
volved in restraint of the tumor. It was found that 3-methylcholanthrene re- 
tarded the growth of these tumors in hypophysectomized rats. 
In the past it has not been possible to prevent the growth of transplanted 
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In the present experiments, it was learned that the injection of either 3-methyl- 
cholanthrene  or dihydrotestosterone slowed  the growth of these tumors but 
to a moderate extent only. These compounds had approximately equal effec- 
tiveness as retarding agents for growth of tumors of this class. But the com- 
bined  administration  of  3-methylcholanthrene  and  dihydrotestosterone  was 
found to be highly efficacious in blocking the growth of these refractory neo- 
plasms; few tumors grew in rats injected with these compounds concurrently, 
and the growth of these neoplasms was very indolent.  It is apparent that the 
compounds  exert  supplementary  effects in  the  control  of  the  transplanted 
tumors. It is noteworthy that dihydrotestosterone, a  steroid which promoted 
anabolic effects in the rat supplemented the anti-neoplastic activity of 3-methyl- 
cholanthrene and provided effective control of the tumor in rats which became 
overweight owing to the presence of the injected androstane derivative. 
SIYMM&Ry 
The  repeated  administration  of  3-methylcholanthrene  to  adolescent  rats 
resulted  in  (a)  a  profound,  incomplete,  and  selective depression  of  certain 
hypophyseal functions; (b) decreased growth of transplanted mammary tumors; 
and (c) a retardation of body growth. Only the last mentioned effect was re- 
versed by forced feeding. 
The  retarded  rate  of body growth  induced  by 3-methylcholanthrene  was 
prevented by the concurrent adm{n{stration  of dihydrotestosterone or proges- 
terone,  or  by ovariectomy; rats  so  treated  became  overweight  despite  the 
injection of 3-methylcholanthrene.  Phenolic estrogens intensified  the retarda- 
tion of body growth induced by 3-methylcholanthrene and emaciation resulted. 
The adm{nistration  of 3-methylcholanthrene  resulted in decreased gonado- 
trophin  production  by the  pituitary  and  the  ovaries were more  drastically 
affected by the depression of pituitary activity than  the adrenals were.  The 
compound exerted differential  effects on  the  pituitary  glands  of males  and 
females respectively. Hormonal functions of both ovary and  testis were de- 
creased in rats treated with 3-methylcholanthrene but, whilst ovarian weight 
was much reduced, the size of the testis was not decreased and the germinal 
epithelium of the male was little affected by the treatment in most instances. 
There was a  considerable reduction of the content of alkaline phosphatase in 
the breast of intact rats treated with 3-methylcholanthrene but atrophy of the 
mammary epithelium did not occur and hyperpiasia of the mammary tree was 
often observed. 
The administration of 3-methylcholanthrene considerably slowed the growth 
of transplanted  mammary tumors characterized  by high  dependence on hor- 
mones and the concurrent aclm{nistration of gonadotrophin restored the growth 
rate of the tumors. 
The administration  of 3-methylcholanthrene or androstan-17~-ol-3-one  was 30  E~IeECTS O~ 3-~[ETIIYLCIIOLANTB2%ENE 
only moderately effective in controlling  the growth of transplanted mammary 
tumors characterized by low hormonal dependence; the combined administra- 
tion of these compounds was highly efficacious in retarding the growth of these 
refractory tumors. 
3-Methylcholanthrene  partially  retarded  the  growth  of  mammary  fibro- 
adenomas in hypophysectomized rats. 
CONCLUSIOIqS 
The repeated administration  of 3-methylcholanthrene  exerted considerable 
effects on endocrine activity and metabolism of the rat and these physiological 
changes were, respectively, intensified  or lessened  by appropriate  steroid or 
nutritional  methods. A selective depression of hypophyseal activity occurred; 
certain gonadotrophin functions were profoundly inhibited and the sex of the 
animal  influenced  the  effects  which  3-methylcholanthrene  exerted  on  the 
pituitary. 
3-Methylcholanthrene  retarded  transplanted  mammary  tumors of the rat 
without inducing  obvious cytologic changes in the neoplasm. The depressive 
effect of 3-methylcholanthrene  on the growth of mammary tumors, hitherto 
refractory to inhibitory influences, was profoundly enhanced by the simultane- 
ous  administration  of  androstan-17~-ol-3-one.  The  inhibition  of  mammary 
tumor growth by these members of the phenanthrene  series administered in 
combination was remarkable. 
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EXPLANATION OF PLATES 
PLATE 2 
Both sections were stained with hematoxylin and eosin. 
FIG. 1. Mammary gland of a normal female rat, age 101 days.  X  135. 
FIG. 2. Mammary gland of a female rat, age 101 days, which had been injected with 
3-methylcholanthrene, 2 rag. for 50 days. Hyperplasia of the mammary epithelium is 
evident.  X  135. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 107  PLATE  2 
(Huggins and Pollice: Effects of 3-methylcholanthrene) PLATE 3 
Fro. 3. Mammary fibroadenomas of class 2 harvested from 4 groups of rats which 
had been injected,  respectively, with  (a) sesame oil; (b)  dihydrotestosterone,  1 mg.; 
(c) 3-methylcholanthrene, 2 rag.; (d) dihydrotestosterone, 1 mg., and 3-methylcholan- 
threne, 2 mg. (the lowest row of tumors).  Natural  size. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  107  ~LAT~  3 
(Huggins and Pollice: Effects of 3-methylcholanthrene) PLATE 4 
FIG. 4. Mammary fibroadenomas of class 2 harvested  from 4 groups of female rats 
which  had  been,  respectively,  untreated;  ovariectomized  (ovariex);  subjected  to 
hypophysectomy;  hypophysectomized  and  injected  with  3-methylcholanthrene, 
0.5 mg. Natural size. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  107  PLATE 4 
(Huggins and Pollice: Effects of 3-methylcholanthrene) 